logo for Bioatla

Bioatla

Business Services · California, United States · 66 Employees

View Company Info for Free

About

Headquarters

11085 Torreyana Rd, San Diego, California, 9212...

Revenue

<$5 Million

Stock Symbol

BCAB

Industry

Drug Manufacturing & Research Pharmaceuticals Healthcare

Who is Bioatla

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services. Utilizing its proprietary Conditionally Active Biologics (CAB) technology, BioAtla develops novel, reversibly active monoclonal antibody and other protein therapeutic product candidates. CAB product candidates are designed to have more selective targeting, greater efficacy with lower toxicity, and more cost-efficient and predictable manufacturing than traditional antibodies. BioAtla has extensive and worldwide patent coverage for its CAB technology and products with more than 500 patents, more than 250 of which are issued. Broad patent coverage in all major markets include methods of making, screening and manufacturing CAB product candidates in a wide range of formats and composition of matter coverage for specific products. BioAtla has two first-in-class CAB programs currently in Phase 2 clinical testing in the United States, mecbotamab vedotin, BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and ozuriftamab vedotin, BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC).Read more

Bioatla's Social MediaPopular SearchesBioatla IncBioAtlaBioatla LLCAtla LLCBioAlto IncSIC Code 28,283NAICS Code 54,541Ticker NASDAQ: BCABShow more

Bioatla Org Chart

Jay Short
Jay Short

Chairman, Chief Executive Officer & Co-Founde...

PhoneEmail
Richard Waldron
Richard Waldron

Senior Vice President & Chief Financial Offic...

PhoneEmail

PhoneEmail

PhoneEmail

Similar Companies to Bioatla

See more similar companies

Bioatla Tech Stack

A closer look at the technologies used by Bioatla

Top Companies in United States

Top 10 companies in United States by revenue

Top 10 companies in United States by number of employees

Top 10 companies in United States by total funding amount

See top companies

Bioatla News & Media

Read more news

Frequently Asked Questions regarding Bioatla

Where is Bioatla located?
Bioatla's headquarters are located at 11085 Torreyana Rd, San Diego, California, 92121, United States
What is Bioatla's stock symbol?
Bioatla's stock symbol is BCAB
What is Bioatla's official website?
Bioatla's official website is www.bioatla.com
What is Bioatla's Revenue?
Bioatla's revenue is <$5 Million
What is Bioatla's SIC code?
Bioatla's SIC: 28,283
What is Bioatla's NAICS code?
Bioatla's NAICS: 54,541
How many employees does Bioatla have?
Bioatla has 66 employees
What industry does Bioatla belong to?
Bioatla is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare
What is Bioatla competition?
Bioatla top competitors include: Visterra Inc, Checkmate Pharmaceuticals, Satsuma Pharmaceuticals, Sensei Biotherapeutics Inc
What technology does Bioatla use?
Some of the popular technologies that Bioatla uses are: Vimeo, Microsoft PowerPoint, Microsoft 365, Microsoft Teams
Who is the CEO of Bioatla?
Bioatla's CEO is Jay Short
Who is the CFO of Bioatla?
Bioatla's CFO is Richard Waldron
What does Bioatla do?

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through our contractual relationship with BioDuro-Sundia, a provider of preclinical development services. Utilizing its proprietary Conditionally Active Biologics (CAB) technology, BioAtla develops novel, reversibly active monocl... onal antibody and other protein therapeutic product candidates. CAB product candidates are designed to have more selective targeting, greater efficacy with lower toxicity, and more cost-efficient and predictable manufacturing than traditional antibodies. BioAtla has extensive and worldwide patent coverage for its CAB technology and products with more than 500 patents, more than 250 of which are issued. Broad patent coverage in all major markets include methods of making, screening and manufacturing CAB product candidates in a wide range of formats and composition of matter coverage for specific products. BioAtla has two first-in-class CAB programs currently in Phase 2 clinical testing in the United States, mecbotamab vedotin, BA3011, a novel conditionally active AXL-targeted antibody-drug conjugate (CAB-AXL-ADC), and ozuriftamab vedotin, BA3021, a novel conditionally active ROR2-targeted antibody-drug conjugate (CAB-ROR2-ADC).Read More

What are Bioatla social media links?
Bioatla Linkedin page Bioatla Facebook page
Is Bioatla a public company?
Yes, Bioatla is a public company and is traded under the symbol BCAB
See more information about Bioatla

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.